Discover CRISPR Gene Editing with FluidFM


Custom CRISPR Gene Editing Service through Direct Intra-nuclear Delivery

CRISPR gene editing precisely cuts DNA, leveraging natural repair mechanisms to modify specific genome locations. [1,2] This adaptability of CRISPR-Cas9 has ignited rapid advancements in diverse fields, from synthetic biology and human gene therapy to neuroscience and agriculture. 


While several gene editing techniques exist, each faces the challenge of efficiently accessing the nucleus to modify the genome without harming the cell. Though CRISPR excels in scenarios needing multiple edits within a single cell line or organism, it sometimes falls short due to low HDR efficiency and off-target effects. 

Presently, the CellEDIT workflow with the FluidFM technology enhances CRISPR's efficiency and versatility in various cell types and is pivotal for cell line engineering and development.


Leverage CellEDIT's expertise to enhance your research capabilities: in 10 weeks, we create for you, custom and monoclonal knockout cell lines through direct intra-nuclear injection, suited for your project needs.


CRISPR Gene Editing with FluidFM - CellEDIT

Vector-free Gene Editing 
by direct intra-nuclear delivery.

Our workflow directly injects CRISPR reagents into the nucleus, removing the need for carriers or vectors and bypassing template size limitations.

CRISPR Gene Editing with FluidFM - CellEDIT

Minimized Off-Targets

Direct intra-nuclear injection delivers all CRISPR components simultaneously and at the correct concentration, effectively minimizing off-target effects.

CRISPR Gene Editing with FluidFM - CellEDIT

Suited for 
Hard-to-Transfect Cells.

CellEDIT's gentle injection workflow uses FluidFM to deliver CRISPR complexes directly into the nucleus, suited for developing cell lines in hard-to-transfect cells.

Get inside the CellEDIT Service

CRISPR Gene Editing - Case Studies

Experience the efficiency of the CellEDIT workflow firsthand. Download our application notes and delve into compelling case studies that demonstrate its transformative impact on immortalized and cancer cell lines.

Cancer Cell Lines

Discover how 
the CellEDIT workflow achieved 3 monoclonal HPRT1 knockouts in the notoriously hard-to-transfect SK-MES-1 cell line.

Immortalized Cell Lines

Explore how 
the CellEDIT workflow generated 5 monoclonal Hprt knockouts in the C2C12 cell line by directly injecting only 51 cells.

Multiplex Editing

Find out how the CellEDIT workflow boosted the editing efficiency while preserving cell characteristics and functionality in single and multiple KO CHO-K1 clones.

Discuss your custom project needs with our experts

References

[1] Jinek, Martin, et al. "A programmable dual-RNA–guided DNA endonuclease in adaptive bacterial immunity." science 337.6096 (2012): 816-821.

[2] Li, Hongyi, et al. "Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects." Signal transduction and targeted therapy 5.1 (2020): 1-23.